Clinical Trial Update: Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase [Phase 4]

View source ↗

Summary

Phase 4 study evaluating nilotinib in adults with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis, accelerated phase, or chronic phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myeloid Leukemia | Phase 4 | Status: COMPLETED